Cargando…

In Vivo Validation of Elekta's Clarity Autoscan for Ultrasound-based Intrafraction Motion Estimation of the Prostate During Radiation Therapy

PURPOSE: Our purpose was to perform an in vivo validation of ultrasound imaging for intrafraction motion estimation using the Elekta Clarity Autoscan system during prostate radiation therapy. The study was conducted as part of the Clarity-Pro trial (NCT02388308). METHODS AND MATERIALS: Initial locat...

Descripción completa

Detalles Bibliográficos
Autores principales: Grimwood, Alexander, McNair, Helen A., O'Shea, Tuathan P., Gilroy, Stephen, Thomas, Karen, Bamber, Jeffrey C., Tree, Alison C., Harris, Emma J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier, Inc 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202949/
https://www.ncbi.nlm.nih.gov/pubmed/29859785
http://dx.doi.org/10.1016/j.ijrobp.2018.04.008
_version_ 1783365787711438848
author Grimwood, Alexander
McNair, Helen A.
O'Shea, Tuathan P.
Gilroy, Stephen
Thomas, Karen
Bamber, Jeffrey C.
Tree, Alison C.
Harris, Emma J.
author_facet Grimwood, Alexander
McNair, Helen A.
O'Shea, Tuathan P.
Gilroy, Stephen
Thomas, Karen
Bamber, Jeffrey C.
Tree, Alison C.
Harris, Emma J.
author_sort Grimwood, Alexander
collection PubMed
description PURPOSE: Our purpose was to perform an in vivo validation of ultrasound imaging for intrafraction motion estimation using the Elekta Clarity Autoscan system during prostate radiation therapy. The study was conducted as part of the Clarity-Pro trial (NCT02388308). METHODS AND MATERIALS: Initial locations of intraprostatic fiducial markers were identified from cone beam computed tomography scans. Marker positions were translated according to Clarity intrafraction 3-dimensional prostate motion estimates. The updated locations were projected onto the 2-dimensional electronic portal imager plane. These Clarity-based estimates were compared with the actual portal-imaged 2-dimensional marker positions. Images from 16 patients encompassing 80 fractions were analyzed. To investigate the influence of intraprostatic markers and image quality on ultrasound motion estimation, 3 observers rated image quality, and the marker visibility on ultrasound images was assessed. RESULTS: The median difference between Clarity-defined intrafraction marker locations and portal-imaged marker locations was 0.6 mm (with 95% limit of agreement at 2.5 mm). Markers were identified on ultrasound in only 3 of a possible 240 instances. No linear relationship between image quality and Clarity motion estimation confidence was identified. The difference between Clarity-based motion estimates and electronic portal–imaged marker location was also independent of image quality. Clarity estimation confidence was degraded in a single fraction owing to poor probe placement. CONCLUSIONS: The accuracy of Clarity intrafraction prostate motion estimation is comparable with that of other motion-monitoring systems in radiation therapy. The effect of fiducial markers in the study was deemed negligible as they were rarely visible on ultrasound images compared with intrinsic anatomic features. Clarity motion estimation confidence was robust to variations in image quality and the number of ultrasound-imaged anatomic features; however, it was degraded as a result of poor probe placement.
format Online
Article
Text
id pubmed-6202949
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier, Inc
record_format MEDLINE/PubMed
spelling pubmed-62029492018-11-15 In Vivo Validation of Elekta's Clarity Autoscan for Ultrasound-based Intrafraction Motion Estimation of the Prostate During Radiation Therapy Grimwood, Alexander McNair, Helen A. O'Shea, Tuathan P. Gilroy, Stephen Thomas, Karen Bamber, Jeffrey C. Tree, Alison C. Harris, Emma J. Int J Radiat Oncol Biol Phys Article PURPOSE: Our purpose was to perform an in vivo validation of ultrasound imaging for intrafraction motion estimation using the Elekta Clarity Autoscan system during prostate radiation therapy. The study was conducted as part of the Clarity-Pro trial (NCT02388308). METHODS AND MATERIALS: Initial locations of intraprostatic fiducial markers were identified from cone beam computed tomography scans. Marker positions were translated according to Clarity intrafraction 3-dimensional prostate motion estimates. The updated locations were projected onto the 2-dimensional electronic portal imager plane. These Clarity-based estimates were compared with the actual portal-imaged 2-dimensional marker positions. Images from 16 patients encompassing 80 fractions were analyzed. To investigate the influence of intraprostatic markers and image quality on ultrasound motion estimation, 3 observers rated image quality, and the marker visibility on ultrasound images was assessed. RESULTS: The median difference between Clarity-defined intrafraction marker locations and portal-imaged marker locations was 0.6 mm (with 95% limit of agreement at 2.5 mm). Markers were identified on ultrasound in only 3 of a possible 240 instances. No linear relationship between image quality and Clarity motion estimation confidence was identified. The difference between Clarity-based motion estimates and electronic portal–imaged marker location was also independent of image quality. Clarity estimation confidence was degraded in a single fraction owing to poor probe placement. CONCLUSIONS: The accuracy of Clarity intrafraction prostate motion estimation is comparable with that of other motion-monitoring systems in radiation therapy. The effect of fiducial markers in the study was deemed negligible as they were rarely visible on ultrasound images compared with intrinsic anatomic features. Clarity motion estimation confidence was robust to variations in image quality and the number of ultrasound-imaged anatomic features; however, it was degraded as a result of poor probe placement. Elsevier, Inc 2018-11-15 /pmc/articles/PMC6202949/ /pubmed/29859785 http://dx.doi.org/10.1016/j.ijrobp.2018.04.008 Text en © 2018 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Grimwood, Alexander
McNair, Helen A.
O'Shea, Tuathan P.
Gilroy, Stephen
Thomas, Karen
Bamber, Jeffrey C.
Tree, Alison C.
Harris, Emma J.
In Vivo Validation of Elekta's Clarity Autoscan for Ultrasound-based Intrafraction Motion Estimation of the Prostate During Radiation Therapy
title In Vivo Validation of Elekta's Clarity Autoscan for Ultrasound-based Intrafraction Motion Estimation of the Prostate During Radiation Therapy
title_full In Vivo Validation of Elekta's Clarity Autoscan for Ultrasound-based Intrafraction Motion Estimation of the Prostate During Radiation Therapy
title_fullStr In Vivo Validation of Elekta's Clarity Autoscan for Ultrasound-based Intrafraction Motion Estimation of the Prostate During Radiation Therapy
title_full_unstemmed In Vivo Validation of Elekta's Clarity Autoscan for Ultrasound-based Intrafraction Motion Estimation of the Prostate During Radiation Therapy
title_short In Vivo Validation of Elekta's Clarity Autoscan for Ultrasound-based Intrafraction Motion Estimation of the Prostate During Radiation Therapy
title_sort in vivo validation of elekta's clarity autoscan for ultrasound-based intrafraction motion estimation of the prostate during radiation therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202949/
https://www.ncbi.nlm.nih.gov/pubmed/29859785
http://dx.doi.org/10.1016/j.ijrobp.2018.04.008
work_keys_str_mv AT grimwoodalexander invivovalidationofelektasclarityautoscanforultrasoundbasedintrafractionmotionestimationoftheprostateduringradiationtherapy
AT mcnairhelena invivovalidationofelektasclarityautoscanforultrasoundbasedintrafractionmotionestimationoftheprostateduringradiationtherapy
AT osheatuathanp invivovalidationofelektasclarityautoscanforultrasoundbasedintrafractionmotionestimationoftheprostateduringradiationtherapy
AT gilroystephen invivovalidationofelektasclarityautoscanforultrasoundbasedintrafractionmotionestimationoftheprostateduringradiationtherapy
AT thomaskaren invivovalidationofelektasclarityautoscanforultrasoundbasedintrafractionmotionestimationoftheprostateduringradiationtherapy
AT bamberjeffreyc invivovalidationofelektasclarityautoscanforultrasoundbasedintrafractionmotionestimationoftheprostateduringradiationtherapy
AT treealisonc invivovalidationofelektasclarityautoscanforultrasoundbasedintrafractionmotionestimationoftheprostateduringradiationtherapy
AT harrisemmaj invivovalidationofelektasclarityautoscanforultrasoundbasedintrafractionmotionestimationoftheprostateduringradiationtherapy